Prana Biotechnology wants to give Alzheimer's disease a prize fight. The biotechnology company is developing therapies for age-related degenerative conditions, including Alzheimer's. Targeting the proteins that build on the brains of Alzheimer's patients, Prana Biotechnology is developing drug candidates to treat the memory-sapping disease. The company aims to develop therapies for other neurological disorders including Parkinson's disease, Huntington's disease, and macular degeneration. Prana, founded in 1997, partners with other pharmaceutical and biotechnology companies.